Prescription Drug Monitoring Programs (PDMPs)
This document provides recommendations for state medical boards and other state agencies to maximize the effective use of PDMPs.
Showing 51-60 of 190 results
This document provides recommendations for state medical boards and other state agencies to maximize the effective use of PDMPs.
The model policy encourages state medical boards promote the public health by making appropriate treatment available to opioid-addicted patients, and to educate the regulatory and physician
FSMB Past Staff Leadership ... Bierring, MD 1961 Stiles D. Ezell, MD 1961–1962 Harold E. Jervey
The guidelines provide an up-to-date resource for state medical and osteopathic boards in assessing physicians’ management of pain in their patients and determining whether opioid analgesics
charset="utf-8" /> www.articulate.com --> ... } www.google-analytics.com/analytics.js'>
charset="utf-8" /> www.articulate.com --> ... } www.google-analytics.com/analytics.js'>
2001 Bryant D. Paris, North Carolina 2003 Dale G. Breaden, North Carolina 2004 Janet D. Carson, JD ... Schiebler, MD, (Individual nonmember) 2009 Larry D. Dixon, Alabama 2010 Trent P. Pierce, MD, Arkansas
charset="utf-8" /> www.articulate.com --> ... } www.google-analytics.com/analytics.js'>
(Euless, Texas, January 14, 2014) – A bipartisan group of 16 U.S. Senators has publicly commended state medical boards and the Federation of State Medical Boards (FSMB) for their recent efforts
Fitzhugh, MD, Maryland 1935–1936 I. D. Metzger, MD, Pennsylvania Medical 1936–1937 ... Leighton, MD, Maine Medical 1946–1947 N. D. Buie, MD, Texas 1947–1948 R. N. Whitfield